Tyndale RF - Search Results

1

Nicotine metabolism defect reduces smoking.

Pianezza ML, Sellers EM, Tyndale RF. Pianezza ML, et al. Among authors: tyndale rf. Nature. 1998 Jun 25;393(6687):750. doi: 10.1038/31623. Nature. 1998. PMID: 9655391 No abstract available.

2

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Schoedel KA, et al. Among authors: tyndale rf. Pharmacogenetics. 2004 Sep;14(9):615-26. doi: 10.1097/00008571-200409000-00006. Pharmacogenetics. 2004. PMID: 15475735

3

Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking.

Mwenifumbo JC, Sellers EM, Tyndale RF. Mwenifumbo JC, et al. Among authors: tyndale rf. Drug Alcohol Depend. 2007 Jun 15;89(1):24-33. doi: 10.1016/j.drugalcdep.2006.11.012. Epub 2006 Dec 8. Drug Alcohol Depend. 2007. PMID: 17161559

4

Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.

Malaiyandi V, Sellers EM, Tyndale RF. Malaiyandi V, et al. Among authors: tyndale rf. Clin Pharmacol Ther. 2005 Mar;77(3):145-58. doi: 10.1016/j.clpt.2004.10.011. Clin Pharmacol Ther. 2005. PMID: 15735609 Review.

5

Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration.

Schoedel KA, Sellers EM, Palmour R, Tyndale RF. Schoedel KA, et al. Among authors: tyndale rf. Mol Pharmacol. 2003 Jan;63(1):96-104. doi: 10.1124/mol.63.1.96. Mol Pharmacol. 2003. PMID: 12488541

6

Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.

Tyndale RF, Sellers EM. Tyndale RF, et al. Ther Drug Monit. 2002 Feb;24(1):163-71. doi: 10.1097/00007691-200202000-00026. Ther Drug Monit. 2002. PMID: 11805739 Review.

7

Molecular genetics of nicotine metabolism.

Mwenifumbo JC, Tyndale RF. Mwenifumbo JC, et al. Among authors: tyndale rf. Handb Exp Pharmacol. 2009;(192):235-59. doi: 10.1007/978-3-540-69248-5_9. Handb Exp Pharmacol. 2009. PMID: 19184652 Review.

8

Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.

Swan GE, Benowitz NL, Lessov CN, Jacob P 3rd, Tyndale RF, Wilhelmsen K. Swan GE, et al. Among authors: tyndale rf. Pharmacogenet Genomics. 2005 Feb;15(2):115-25. doi: 10.1097/01213011-200502000-00007. Pharmacogenet Genomics. 2005. PMID: 15861035

9

Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.

Ring HZ, Valdes AM, Nishita DM, Prasad S, Jacob P 3rd, Tyndale RF, Swan GE, Benowitz NL. Ring HZ, et al. Among authors: tyndale rf. Pharmacogenet Genomics. 2007 Dec;17(12):1007-15. doi: 10.1097/01.fpc.0000220560.59972.33. Pharmacogenet Genomics. 2007. PMID: 18004205

10

The role of CYP2A6 in the emergence of nicotine dependence in adolescents.

Audrain-McGovern J, Al Koudsi N, Rodriguez D, Wileyto EP, Shields PG, Tyndale RF. Audrain-McGovern J, et al. Among authors: tyndale rf. Pediatrics. 2007 Jan;119(1):e264-74. doi: 10.1542/peds.2006-1583. Epub 2006 Nov 27. Pediatrics. 2007. PMID: 17130279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results